Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,224,133 papers from all fields of science
Search
Sign In
Create Free Account
Prominin-1, human
Known as:
Prominin-like protein 1
, Prominin-1
, CD133 Antigen
Expand
Prominin-1 (865 aa, ~97 kDa) is encoded by the human PROM1 gene. This protein may play a role in hematopoiesis, but an exact function has yet to be…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (1)
AC133 antigen
Eye Development
Genes, Regulator
Integral Membrane Proteins
PROM1 gene
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Is CD 133 a marker of metastatic colon cancer stem cells ?
Mark A. LaBarge
2018
Corpus ID: 73693649
The concept of the so-called cancer stem cell (CSC) holds that only a minority of cells within a tumor have the ability to…
Expand
2018
2018
Expression and clinical significance of stem cell marker CD 133 in human neuroblastoma
Q. Tong
,
Li-duan Zheng
,
+5 authors
Jia-bin Cai
2018
Corpus ID: 43057211
Results: The expression rates of CD133 in NB and GNB were 46.9% (15/32) and 37.5% (3/8) respectively, mainly in cytoplasm of…
Expand
2017
2017
Aberrant expression of CD133 and CD82 in patients with pediatric acute lymphoblastic leukemia and the clinical significance
Hongyan Ji
,
Li Chen
,
+7 authors
Yulin Wang
Oncology Letters
2017
Corpus ID: 31577189
Cluster of differentiation (CD)133 is considered to be a marker of leukemia stem cells (LSCs), which are one of the primary…
Expand
2016
2016
Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
Xing Wu
,
F. Wu
,
Dongwen Xu
,
Tao Zhang
Journal of Neuro-Oncology
2016
Corpus ID: 32022527
CD133 has played a pivotal role in the identification and isolation of brain tumor stem cells. The correlation between CD133…
Expand
2016
2016
Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population
Qing-Feng Liu
,
Zhi-fei Zhang
,
Guangjie Hou
,
Guang-Yu Yang
,
Yinli He
Lung
2016
Corpus ID: 30928056
ObjectiveTo explore the association of functional single-nucleotide polymorphisms (SNPs) of CD133 with the risk of lung cancer…
Expand
2016
2016
Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells
Paula Müller
,
N. Voronina
,
+4 authors
R. David
Stem Cells International
2016
Corpus ID: 20022641
Aim. CD133+ stem cells bear huge potential for regenerative medicine. However, low retention in the injured tissue and massive…
Expand
2013
2013
Expression of CD 133 in acute leukemia
F. Tolba
,
M. E. Foda
,
H. Kamal
,
Deena A. Elshabrawy
2013
Corpus ID: 19263159
There have been conflicting results regarding a correlation between CD133 expression and disease outcome. To assess CD133…
Expand
2011
2011
Is CD 133 a biomarker for cancer stem cells of colorectal cancer and brain tumors ? A meta-analysis
Kun Yang
,
Xin-Zu Chen
,
+6 authors
Jian-kun Hu
2011
Corpus ID: 17060257
Background: CD133 has been used to identify normal and cancer stem cells from several different tissues. Nowadays some…
Expand
2009
2009
Elevated CD 133 , but not VEGF or EGFR , as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer
H. Yasuda
,
Koji Tanaka
,
+8 authors
M. Kusunoki
2009
Corpus ID: 9169164
CD133 has been postulated to be a colon cancer stem cell (CSCs) marker. Recent investigations suggest that CSCs might contribute…
Expand
2009
2009
CD 44 and CD 133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients
S. Maeda
,
D. Qiang
,
+5 authors
S. Takao
2009
Corpus ID: 10247659
Background: Recent studies have suggested that CD44 and/or CD133 expressing pancreatic cancer cells have potential abilities of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE